Exploring how retroviruses can enhance the immune system's ability to fight infections
Reverse transcriptase-mediated expansion of the host innate immune system
This study is looking at how certain immune genes, which come from retroviruses, can help our bodies fight off viral infections better, and it's for anyone interested in understanding why some people get sick more easily than others.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Pacific Northwest Research Institute NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10753557 on NIH RePORTER |
What this research studies
This research investigates the role of newly identified immune genes, created by retroviruses, in enhancing the body's response to viral infections. By examining genetic variations in these retrocopies, the study aims to understand how they influence individual susceptibility to diseases. The approach involves advanced genetic sequencing techniques to identify and analyze these retrocopies in human and primate genomes. This could lead to new insights into immune responses and potential therapeutic targets for infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with varying susceptibility to viral infections, particularly those with a family history of infectious diseases.
Not a fit: Patients with no history of viral infections or those who do not have genetic variations in innate immunity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating viral infections by harnessing the body's innate immune responses.
How similar studies have performed: Previous studies have shown promise in understanding the role of genetic variations in immune responses, suggesting that this approach could yield valuable insights.
Where this research is happening
Seattle, United States
- Pacific Northwest Research Institute — Seattle, United States (Active)
Researchers
- Principal investigator: Mclaughlin, Richard Noel — Pacific Northwest Research Institute
- Study coordinator: Mclaughlin, Richard Noel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.